416
Participants
Start Date
August 31, 2012
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
Paclitaxel
intravenous paclitaxel 80 mg/m2 per week given until progression
BKM120 matching placebo
"Buparlisib maching plaxcebo were supplied as 100 mg and 50 mg hard gelatin capsules.~Buparlisib placebo was dosed on a flat scale of mg/day and was not adjusted to body weight or body surface area."
BKM120
Buparlisib (BKM120) were supplied as 100 mg and 50 mg hard gelatin capsules. Buparlisib was dosed on a flat scale of mg/day and was not adjusted to body weight or body surface area.
Novartis Investigative Site, Budapest
Novartis Investigative Site, Ottignies
Novartis Investigative Site, Sydney
Novartis Investigative Site, Johannesburg
Novartis Investigative Site, Wilrijk
Novartis Investigative Site, Parkville
Novartis Investigative Site, Geelong
Novartis Investigative Site, Liège
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Salzburg
Novartis Investigative Site, Charleroi
Novartis Investigative Site, Nedlands
Novartis Investigative Site, Sint-Niklaas
Novartis Investigative Site, Taipei
New York Oncology Hematology, P.C. Dept. of New York Oncology. PC, Troy
Novartis Investigative Site, Marseille
Novartis Investigative Site, Córdoba
Novartis Investigative Site, A Coruña
Novartis Investigative Site, Genova
Novartis Investigative Site, Milan
Medical Oncology & Hematology Associates of Northern VA Med Onc Hem Northern VA, Reston
Novartis Investigative Site, Monza
Novartis Investigative Site, New Taipei City
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Málaga
Northwest Georgia Oncology Center NW Georgia Onc, Marietta
Emory University School of Medicine/Winship Cancer Institute Dept.of WinshipCancerInst. (2), Atlanta
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Kuei-Shan Chiang
H. Lee Moffitt Cancer Center & Research Institute SC, Tampa
Novartis Investigative Site, Fulda
Novartis Investigative Site, San Cristóbal de La Laguna
Norton Healthcare, Inc., Louisville
Novartis Investigative Site, Seville
Ohio State Comprehensive Cancer Center/James Cancer Hospital SC-1, Columbus
Novartis Investigative Site, Cona
Novartis Investigative Site, Saint-Herblain
Novartis Investigative Site, Valencia
Novartis Investigative Site, Valencia
Novartis Investigative Site, Angers
Novartis Investigative Site, Zaragoza
Novartis Investigative Site, Bonn
Novartis Investigative Site, Mainz
Novartis Investigative Site, Frankfurt
Washington University School of Medicine Regulatory, St Louis
University of Kansas Cancer Center Univ Kansas 2, Kansas City
University of Nebraska Medical Center Unv Nebraska Med Ctr (2), Omaha
Novartis Investigative Site, Le Mans
Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville
University of Oklahoma Health Sciences Center OUHSC 2, Oklahoma City
Baylor Health Care System/Sammons Cancer Center Baylor Texas Oncology, Dallas
University of Texas Southwestern Medical Center Harry Hines, Dallas
Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio, San Antonio
Novartis Investigative Site, München
Ironwood Cancer and Research Centers SC, Chandler
Novartis Investigative Site, La Roche-sur-Yon
University of New Mexico Cancer Research Center Dept of Univ New Mexico, Albuquerque
Novartis Investigative Site, Ravensburg
Novartis Investigative Site, Ulm
Novartis Investigative Site, Erlangen
Novartis Investigative Site, Créteil
Novartis Investigative Site, Villejuif
California Cancer Care Marian Speciality, Greenbrae
Northwest Cancer Specialists Vancouver Loc, Portland
Novartis Investigative Site, Messina
Novartis Investigative Site, Singapore
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Ramat Gan
Novartis Investigative Site, Tel Aviv
Arizona Oncology Associates Dept of Oncology, Phoenix
Rocky Mountain Cancer Centers RMCC Hale Pkwy, Greenwood Village
Novartis Investigative Site, Hong Kong SAR
Novartis Investigative Site, London
Novartis Investigative Site, Vienna
Novartis Investigative Site, Fortaleza
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Montreal
Novartis Investigative Site, Brno
Novartis Investigative Site, Olomouc
Novartis Investigative Site, Prague
Novartis Investigative Site, Nice
Novartis Investigative Site, Dresden
Novartis Investigative Site, Szolnok
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Koto
Novartis Investigative Site, Isehara
Novartis Investigative Site, Kawasaki
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Kumamoto
Novartis Investigative Site, Osaka
Novartis Investigative Site, Osaka
Novartis Investigative Site, Suita
Novartis Investigative Site, Breda
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Maidstone
Novartis Investigative Site, Glasgow - Scotland
Novartis Investigative Site, Metropolitan Borough of Wirral
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY